Vivian W Y Lui Selected Research

Vivian W Y Lui Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 10/2003
11	Squamous Cell Carcinoma of Head and Neck 11/2020 - 10/2003
7	Nasopharyngeal Carcinoma 02/2014 - 12/2009
4	Carcinogenesis 01/2021 - 12/2009
3	Head and Neck Neoplasms (Head and Neck Cancer) 07/2013 - 03/2009
2	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2015
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2016
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2014 - 02/2013
2	Hepatocellular Carcinoma (Hepatoma) 06/2013 - 10/2011
1	Epstein-Barr Virus Infections 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Disease Progression 01/2017
1	Lymphatic Metastasis 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Infections 01/2015
1	Inflammation (Inflammations) 01/2014
1	Genomic Instability 01/2014
1	Necrosis 12/2011
1	Hypoxia (Hypoxemia) 06/2011
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2010

Drug/Important Bio-Agent (IBA)

5	ErbB Receptors (EGF Receptor)IBA 01/2020 - 03/2009
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2011
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 03/2009
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 04/2016 - 05/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2016 - 05/2015
2	NucleotidesIBA 01/2016 - 01/2014
2	Everolimus FDA Link 06/2013 - 08/2010
2	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 08/2010
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 11/2020
1	16S Ribosomal RNAIBA 11/2020
1	human ERBB2 proteinIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Gastrin-Releasing PeptideIBA 11/2018
1	matrigelIBA 11/2018
1	protein kinase DIBA 11/2018
1	Small Interfering RNA (siRNA)IBA 11/2018
1	BombesinIBA 11/2018
1	Doxycycline (Periostat)FDA LinkGeneric 11/2018
1	Protein Kinases (Protein Kinase)IBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	AmphiregulinIBA 04/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2016
1	src-Family KinasesIBA 01/2016
1	Discoidin Domain Receptor 2IBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 01/2016
1	AZD 1480IBA 03/2015
1	Phosphotransferases (Kinase)IBA 03/2015
1	Janus KinasesIBA 03/2015
1	rat MIRN466 microRNAIBA 01/2015
1	dactolisibIBA 02/2014
1	PyrinIBA 01/2014
1	Leucine (L-Leucine)FDA Link 01/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2013
1	MK 2206IBA 06/2013
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 06/2013
1	AZD 6244IBA 02/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2013
1	Sunitinib (Sutent)FDA Link 12/2011
1	Docetaxel (Taxotere)FDA Link 12/2011
1	Biological ProductsIBA 10/2011
1	Oncogene Proteins (Oncogene Protein)IBA 06/2011
1	Tirapazamine (SR 4233)IBA 06/2011
1	Free RadicalsIBA 06/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2011
1	ProdrugsIBA 06/2011
1	AcidsIBA 11/2010
1	TOR Serine-Threonine KinasesIBA 08/2010
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2010
1	Gefitinib (Iressa)FDA Link 06/2010
1	cucurbitacin IIBA 12/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2009
1	Antisense DNAIBA 03/2009
1	CarbonIBA 10/2003
1	IsothiocyanatesIBA 10/2003
1	phenylisothiocyanateIBA 10/2003
1	benzyl isothiocyanateIBA 10/2003

Therapy/Procedure

5	Therapeutics 11/2018 - 03/2009
1	Adjuvant Radiotherapy 01/2018
1	Radiotherapy 01/2018
1	Precision Medicine 01/2016
1	Oral Administration 03/2015
1	Drug Therapy (Chemotherapy) 12/2011